Barclays’s HCW Biologics HCWB Stock Holding History
Bought
Maintained
Sold
Other funds holding HCWB
Barclays's HCWB Position: Q3 2026 in Review
Barclays sold out of HCW Biologics (HCWB) in Q3 2026, closing a stake of 191 shares — an estimated $953 sold.
Barclays first reported a position in HCWB in Q2 2026 and held it in 1 quarter. The position peaked at $953 in Q2 2026. 12 funds tracked by Wall St. Rank hold HCWB as of Q3 2026.
- Barclays reported no remaining HCW Biologics position as of Q3 2026 after selling out during the quarter.
- Barclays sold 191 HCW Biologics shares in Q3 2026, an estimated $953.
- Barclays first reported a position in HCW Biologics in Q2 2026 and held it in 1 quarter.
- Barclays's HCW Biologics position peaked at $953 in Q2 2026.
- 12 funds tracked by Wall St. Rank held HCW Biologics as of Q3 2026.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.